These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
972 related items for PubMed ID: 24249617
1. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease. Ender KL, Krajewski JA, Babineau J, Tresgallo M, Schechter W, Saroyan JM, Kharbanda A. Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617 [Abstract] [Full Text] [Related]
2. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation. Kato-Lin YC, Krishnamurti L, Padman R, Seltman HJ. Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666 [Abstract] [Full Text] [Related]
3. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management. Tanabe P, Artz N, Mark Courtney D, Martinovich Z, Weiss KB, Zvirbulis E, Hafner JW. Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779 [Abstract] [Full Text] [Related]
4. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care. Allen Liles E, Kirsch J, Gilchrist M, Adem M. Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786 [Abstract] [Full Text] [Related]
5. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease. Mathias MD, McCavit TL. Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245 [Abstract] [Full Text] [Related]
6. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department. Kavanagh PL, Sprinz PG, Wolfgang TL, Killius K, Champigny M, Sobota A, Dorfman D, Barry K, Miner R, Moses JM. Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933 [Abstract] [Full Text] [Related]
7. Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease. Inoue S, Khan I, Mushtaq R, Sanikommu SR, Mbeumo C, LaChance J, Roebuck M. Ann Hematol; 2016 Jan; 95(2):221-5. PubMed ID: 26611852 [Abstract] [Full Text] [Related]
8. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis. Yaster M, Tobin JR, Billett C, Casella JF, Dover G. Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746 [Abstract] [Full Text] [Related]
9. Approach to the vaso-occlusive crisis in adults with sickle cell disease. Yale SH, Nagib N, Guthrie T. Am Fam Physician; 2000 Mar 01; 61(5):1349-56, 1363-4. PubMed ID: 10735342 [Abstract] [Full Text] [Related]
10. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis. Hardwick WE, Givens TG, Monroe KW, King WD, Lawley D. Pediatr Emerg Care; 1999 Jun 01; 15(3):179-82. PubMed ID: 10389953 [Abstract] [Full Text] [Related]
11. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain. Morrissey LK, Shea JO, Kalish LA, Weiner DL, Branowicki P, Heeney MM. Pediatr Blood Cancer; 2009 Mar 01; 52(3):369-72. PubMed ID: 19023890 [Abstract] [Full Text] [Related]
12. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease. De Franceschi L, Mura P, Schweiger V, Vencato E, Quaglia FM, Delmonte L, Evangelista M, Polati E, Olivieri O, Finco G. Pain Pract; 2016 Jul 01; 16(6):680-7. PubMed ID: 26009799 [Abstract] [Full Text] [Related]
13. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease. Krishnamoorthy P, Alyaarubi S, Abish S, Gale M, Albuquerque P, Jabado N. Pediatrics; 2006 Aug 01; 118(2):e537-9. PubMed ID: 16882790 [Abstract] [Full Text] [Related]
14. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Buchanan ID, Woodward M, Reed GW. Pediatr Blood Cancer; 2005 Oct 15; 45(5):716-24. PubMed ID: 15926170 [Abstract] [Full Text] [Related]
15. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization. Binding A, Ward R, Phua C, Naessens V, O'Brien T, Bhatia S, Baranek H, Marani H, Mukerji G. CJEM; 2019 Jan 15; 21(1):55-62. PubMed ID: 29039292 [Abstract] [Full Text] [Related]
16. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department. García-Morin M, López-Sangüos C, Vázquez P, Alvárez T, Marañón R, Huerta J, Cela E. Hemoglobin; 2016 Nov 15; 40(6):388-391. PubMed ID: 28361592 [Abstract] [Full Text] [Related]
17. Emergency department management of acute pain episodes in sickle cell disease. Tanabe P, Myers R, Zosel A, Brice J, Ansari AH, Evans J, Martinovich Z, Todd KH, Paice JA. Acad Emerg Med; 2007 May 15; 14(5):419-25. PubMed ID: 17389246 [Abstract] [Full Text] [Related]
18. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis. Shah SP, Twilla JD, Kemp L, Phelps GL, Reaves A. J Pain Palliat Care Pharmacother; 2018 Dec 15; 32(4):201-207. PubMed ID: 30896312 [Abstract] [Full Text] [Related]
19. Impact of individualized pain plan on the emergency management of children with sickle cell disease. Krishnamurti L, Smith-Packard B, Gupta A, Campbell M, Gunawardena S, Saladino R. Pediatr Blood Cancer; 2014 Oct 15; 61(10):1747-53. PubMed ID: 24962217 [Abstract] [Full Text] [Related]
20. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study. Nottage KA, Hankins JS, Faughnan LG, James DM, Richardson J, Christensen R, Kang G, Smeltzer M, Cancio MI, Wang WC, Anghelescu DL. Clin Trials; 2016 Aug 15; 13(4):409-16. PubMed ID: 27000103 [Abstract] [Full Text] [Related] Page: [Next] [New Search]